Thomas Haughey

Thomas Haughey

Chief Administrative Officer chez PAR PHARMACEUTICAL COMPANIES, INC.

Fortune : 3 M $ au 31/03/2024

60 ans
Health Technology
Consumer Services
Commercial Services

Profil

Mr. Thomas J.
Haughey
is a Lead Independent Director at ANI Pharmaceuticals, Inc., a Chief Administrative Officer & General Counsel at Endo Generics Holdings, Inc. and a Treasurer & Vice President at Star CNC Machine Tool Corp.
He is on the Board of Directors at ANI Pharmaceuticals, Inc. Mr. Haughey was previously employed as a Secretary & General Counsel by Par Pharmaceutical, Inc., a Legal Director-Licensing by Schering-Plough Corp., and an Attorney by Cadwalader, Wickersham & Taft LLP.
He received his undergraduate degree from St. John's University and a graduate degree from New York University School of Law.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/03/2024 47 116 ( 0,22% ) 3 M $ 31/03/2024

Postes actifs de Thomas Haughey

SociétésPosteDébut
PAR PHARMACEUTICAL COMPANIES, INC. Chief Administrative Officer 01/10/2008
ANI PHARMACEUTICALS, INC. Director/Board Member 01/05/2018
Treasurer 30/09/2009
Tous les postes actifs de Thomas Haughey

Anciens postes connus de Thomas Haughey

SociétésPosteFin
President 01/01/2012
General Counsel 01/01/2003
Corporate Officer/Principal -
Voir l'expérience en détail de Thomas Haughey

Formation de Thomas Haughey

St. John's University Undergraduate Degree
New York University School of Law Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Thomas Haughey

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
ANI PHARMACEUTICALS, INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Commercial Services

Health Technology

Producer Manufacturing

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Thomas Haughey